Form 4: ProAssurance Exec Granted 23,720 Restricted Stock Units

ProAssurance Corporation's President of Healthcare Professional Liability, Robert David Francis, was granted 23,720 Restricted Stock Units.

Summary

• Robert David Francis, President of Healthcare Professional Liability at ProAssurance Corp (PRA), reported the acquisition of 23,720 Restricted Stock Units (RSUs).
• The transaction date for this specific grant was January 7, 2026.
• These RSUs were issued from the ProAssurance Corporation 2014 Equity Incentive Compensation Plan.
• The newly acquired 23,720 RSUs will vest pro rata in one-third increments in each of the years 2027, 2028, and 2029.
• Following this transaction, Robert David Francis beneficially owns a total of 62,143 Restricted Stock Units directly.
• Other previously granted RSUs include 17,668 units (vesting 2026-2028), 17,529 units (vesting 2025-2027), and 3,226 units (vesting 2024-2026).
• Vesting is contingent on continuous employment with ProAssurance or its subsidiaries until each vesting date.
• Vesting can accelerate upon termination due to death, disability, or 'Good Reason' as defined in the employment agreement, or by action of the Compensation Committee.
• The RSUs will be settled in shares of ProAssurance Common Stock and cash, with the cash portion covering federal, state, and local taxes.

Sentiment

Score: 7

Explanation: The filing indicates a routine executive compensation event, which is generally positive for executive retention and alignment with shareholder interests. It does not present any immediate negative implications for the company's operational or financial health.

Positives

• The grant of Restricted Stock Units aligns the executive's long-term interests with those of shareholders, incentivizing sustained performance.
• The vesting schedule over multiple years promotes executive retention by requiring continuous employment for the full benefit.

Negatives

• The grant of RSUs, while common, represents potential future dilution for existing shareholders when the units vest and convert to common stock.

Risks

• The vesting of RSUs is contingent on continuous employment, meaning the executive risks forfeiture if employment terminates before vesting dates, unless specific acceleration conditions (death, disability, Good Reason) are met.
• The value of the RSUs upon vesting is subject to the market price fluctuations of ProAssurance Corporation common stock.

Future Outlook

The RSU grants are designed to incentivize the executive's long-term commitment and performance, aligning their financial interests with the future success and shareholder value of ProAssurance Corporation through 2029.

Industry Context

The grant of Restricted Stock Units to key executives is a common and widely accepted practice in the insurance and broader financial services industry for executive compensation, aiming to attract, retain, and motivate top talent by linking their compensation to company performance and shareholder returns.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a standard practice across publicly traded companies, including those in the insurance sector, to align executive incentives with long-term shareholder value.
• The multi-year, pro-rata vesting schedule is typical for RSU grants, similar to compensation structures observed at peer companies in the professional liability insurance market.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential long-term benefit from increased executive alignment and retention, but also potential future dilution upon RSU vesting.
• Employees (Executive): Direct financial benefit and incentive for continued service and performance.

Next Steps

• The granted Restricted Stock Units will vest in one-third increments annually, starting in 2027 and continuing through 2029, contingent on the executive's continuous employment.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation grant of Restricted Stock Units, which is a positive for executive retention and alignment with shareholder interests. However, it does not contain information that would fundamentally alter the investment thesis for ProAssurance Corporation, hence a 'hold' recommendation is appropriate based solely on this filing.

Keywords

ProAssurance, PRA, Restricted Stock Units, RSU, Executive Compensation, Form 4, Equity Incentive Plan, Insider Transaction, Robert David Francis